← Open Payments lookup

MELISSA HAKES: Open Payments

NPI 1659149847 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$924 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,029 · 2025 $924

Food & beverage: $924
CompanyPaymentsAmount
Madrigal Pharmaceuticals2$229
Takeda Pharmaceuticals U.S.A., Inc.5$128
ABBVIE INC.1$125
Janssen Biotech, Inc.3$85
Gilead Sciences, Inc.4$71
GENZYME CORPORATION2$64
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$57
Lilly USA, LLC2$56
Phathom Pharmaceuticals, Inc.1$36
Ardelyx, Inc.1$32

Products named: REZDIFFRA, MAVYRET, ENTYVIO, DUPIXENT, TREMFYA, XIFAXAN, OMVOH, VOQUEZNA.

Industry payments across AZ — which companies pay providers there.